PEXA B Stock Overview
Develops and commercializes diagnostic products in various respiratory diseases. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PExA AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.16 |
| 52 Week High | SEK 0.55 |
| 52 Week Low | SEK 0.15 |
| Beta | 1.27 |
| 1 Month Change | -27.19% |
| 3 Month Change | -35.51% |
| 1 Year Change | -59.59% |
| 3 Year Change | -83.01% |
| 5 Year Change | -94.63% |
| Change since IPO | -95.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| PEXA B | SE Life Sciences | SE Market | |
|---|---|---|---|
| 7D | -17.3% | 6.3% | 6.8% |
| 1Y | -59.6% | -7.1% | -6.9% |
Return vs Industry: PEXA B underperformed the Swedish Life Sciences industry which returned -7.1% over the past year.
Return vs Market: PEXA B underperformed the Swedish Market which returned -6.9% over the past year.
Price Volatility
| PEXA B volatility | |
|---|---|
| PEXA B Average Weekly Movement | 21.5% |
| Life Sciences Industry Average Movement | 9.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in SE Market | 14.0% |
| 10% least volatile stocks in SE Market | 4.2% |
Stable Share Price: PEXA B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: PEXA B's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 3 | Tomas Gustafsson | pexa.se |
PExA AB (publ) develops and commercializes diagnostic products in various respiratory diseases. It offers its products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases. The company’s research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways.
PExA AB (publ) Fundamentals Summary
| PEXA B fundamental statistics | |
|---|---|
| Market cap | SEK 9.90m |
| Earnings (TTM) | -SEK 10.16m |
| Revenue (TTM) | SEK 719.62k |
12.8x
P/S Ratio-0.9x
P/E RatioIs PEXA B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PEXA B income statement (TTM) | |
|---|---|
| Revenue | SEK 719.62k |
| Cost of Revenue | SEK 393.29k |
| Gross Profit | SEK 326.33k |
| Other Expenses | SEK 10.49m |
| Earnings | -SEK 10.16m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 09, 2025
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 45.35% |
| Net Profit Margin | -1,412.24% |
| Debt/Equity Ratio | 0% |
How did PEXA B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/15 19:48 |
| End of Day Share Price | 2025/04/15 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PExA AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.